The widespread nature of the opioid epidemic will require coordination from a variety of stakeholders and all levels of government. In this podcast, experts discuss how the crisis got so out of hand, various tactics being undertaken to reverse the opioid, and the current impact of stigma on getting treatment.
The widespread nature of the opioid epidemic will require coordination from a variety of stakeholders and all levels of government, according to experts. In a series of interviews, Barbara Cimaglio, of the Vermont Department of Health; Kelly J. Clark, MD, MBA, of the American Society of Addiction Medicine; Patrice A. Harris, MD, MA, of the American Medical Association; and Mark McGrail, MD, of Cherokee Health Systems, outline how the crisis got so out of hand, various tactics being undertaken to reverse the opioid, and the current impact of stigma on getting treatment.
Read the article.
See the infographic.
Listen to the podcast above or at one of these services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More